$GLMD
Galmed Pharmaceuticals Ltd.
XNAS
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is GLMD up today? It is at $4.66 (+0.00%), and our scanner flagged it 27 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GLMD spikes, and full due diligence on GLMD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GLMD 27 times in the last 30 days. Create a free account to track $GLMD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on GLMD from our scanner (live price and day move above). Fresh from the SEC: Galmed Pharmaceuticals Ltd. filed a Foreign issuer report (6-K). A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystForeign issuer report (6-K), from an SEC filing. Read it →* Institutional ownership was unavailable, so float is insider-deduped only.
Across every filing on file, supply equal to 90.7% of the tradeable float is in play - 90.7% has already been sold.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
937,500 new shares (adjusted for the later reverse split)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


Here is the latest on GLMD from our scanner (live price and day move above). Fresh from the SEC: Galmed Pharmaceuticals Ltd. filed a Foreign issuer report (6-K). A material company disclosure like this is often the real catalyst behind a move of this size.
GLMD last traded at $4.66, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The GLMD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GLMD 27 times in the last 30 days.
GLMD (Galmed Pharmaceuticals Ltd.) trades on XNAS, with a market cap of about $4M.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GLMD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GLMD discussion
Sign in to ask a question or join the discussion.